News Search

Roshi Rao and Christine Rohde share insight on who might consider prophylactic mastectomy, what the procedure involves, and what patients should know before making this decision.

Columbia scientists created a long-lasting type of TFF2 that reprograms immune cells in gastric tumors, boosting cancer therapy response and offering potential for broader immune disease treatment.

Columbia scientists are conducting the first census of cells in tissues of the aging human immune system and finding that some older immune cells retain their youthful vigor and abilities.

Faculty at the Herbert Irving Comprehensive Cancer Center advance global cancer research through breakthroughs in bone marrow transplantation, DNA sequencing, and lab-grown organ development.